Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » What are Neuroendocrine Cancers?​ » Metastatic Neuroendocrine Cancer

Understanding Metastatic Neuroendocrine Cancer

A comprehensive guide to metastatic NETs

Neuroendocrine cancers (also known as NETs) are a group of less common cancers originating from neuroendocrine cells throughout the body. While not as common as some other cancer types, metastatic neuroendocrine cancer presents its own unique characteristics and challenges.

Metastatic neuroendocrine cancer has a significant impact on those diagnosed with it, and their families. With early detection, appropriate treatment, and a strong support system, individuals can navigate the challenges posed by metastatic NETs.

Every patient’s experience is unique, and there are dedicated medical professionals and support networks available to provide guidance, care, and compassion throughout this process.

On this page, we will delve into metastatic neuroendocrine cancer, offering information and support for those affected by this condition. If you have specific questions about your condition, you should consult your healthcare team or contact our NET Nurse.

What is metastatic neuroendocrine cancer?

Neuroendocrine cancer is cancer originating from specialised neuroendocrine cells found throughout the body, primarily in organs such as the lungs, pancreas, gastrointestinal tract, and adrenal glands. These cells play a vital role in regulating various physiological functions, including hormone secretion and nerve signalling.

When neuroendocrine tumours become cancerous and spread (metastasise) to other parts of the body, they are referred to as metastatic neuroendocrine cancer. The metastatic process involves cancer cells breaking away from the primary tumour and travelling through the bloodstream or lymphatic system to form secondary tumours in distant organs or tissues. The most common sites of metastasis for neuroendocrine tumours include the liver, lungs, and lymph nodes.

Risk factors and causes of metastatic neuroendocrine cancer

The exact causes of metastatic neuroendocrine cancer remain unknown. However, several risk factors have been identified that may increase the likelihood of developing these tumours:

Inherited syndromes

Some individuals may have a genetic predisposition to neuroendocrine tumours due to certain hereditary conditions. Such as Multiple endocrine neoplasia types (MEN1 & 2), Von Hippel Lindau syndrome, medullary thyroid cancer (MTC).

Delayed Diagnosis

60% of NET patients are Stage 4 at correct diagnosis.

Recognising the symptoms of metastatic neuroendocrine cancer

Symptoms of metastatic neuroendocrine cancer can vary widely depending on the subtype and location of the tumour. Recognizing these symptoms early can lead to a prompt diagnosis and appropriate treatment. Common symptoms may include:

  • Abdominal pain: Discomfort or pain in the abdominal area, especially in cases involving gastrointestinal neuroendocrine tumours.
  • Coughing and respiratory symptoms: Persistent cough, wheezing, or difficulty breathing, particularly in lung neuroendocrine tumours.
  • Hormone-related symptoms: Some neuroendocrine tumours can produce hormones that lead to symptoms like flushing, diarrhoea, or changes in blood sugar levels.
  • Unexplained weight loss: Significant and unexplained weight loss over a relatively short period.
  • Fatigue: Persistent fatigue and weakness that doesn’t improve with rest.

Diagnosis and staging of metastatic neuroendocrine cancer

Diagnosing and staging metastatic neuroendocrine cancer is a meticulous process involving various medical assessments. The manner in which these are actioned will depend on the patient, their condition, and the location of the tumour.

Imaging studies

Imaging studies involve taking imagery to assess the size and state of the tumour.

  • CT scans: Computed tomography scans are used to visualise the tumours, their size, and their spread to nearby organs or lymph nodes.
  • MRI scans: Magnetic resonance imaging provides detailed images and can be particularly useful for assessing brain and spinal cord involvement.
  • Ga68 Dotatate PET & FDG PET scans: detect neuroendocrine tumours, receptors and activity.

Biopsy

A biopsy is a medical procedure in which a sample of a metastatic neuroendocrine tumour is taken from a person’s body for examination and analysis. The purpose of a biopsy is to diagnose and stage the tumour.

  • Endoscopy: A flexible tube with a camera is inserted through the mouth or other openings to visualise and collect tissue samples from the gastrointestinal tract.
  • Fine-Needle Aspiration (FNA): A thin, hollow needle is used to withdraw a small tissue sample for analysis.
  • Surgical biopsy: In some cases, surgical procedures are required to obtain tissue samples for confirmation and subtype determination..

Grading

Grading identifies the cell ‘s differentiation and rate of growth which assists treatment choice.

Staging

Staging helps determine the extent of the cancer’s spread and guides treatment decisions. The staging system for neuroendocrine cancer is covered extensively on our page on staging.

Surgery

Surgical removal of the tumour, especially when it’s localised or causing symptoms. This is commonly done for gastrointestinal neuroendocrine tumours. In some cases, surgery may be used to remove as much of the tumour (debulking) as possible when it has spread to multiple areas. This is often combined with other treatments.

Medical therapies

Medical therapies may be employed to assist in the management of a metastatic neuroendocrine tumour.

  • Chemotherapy: Chemotherapy drugs are used to kill cancer cells throughout the body. They are commonly employed for high-grade neuroendocrine tumours (NETs) and neuroendocrine carcinomas (NECs)metastatic disease
  • Targeted therapies: These drugs target specific molecules involved in cancer growth and can be effective in certain subtypes of metastatic neuroendocrine tumours.
  • Somatostatin Analogues: These medications can help control hormone-related symptoms and slow tumour growth..
  • Peptide Receptor Radionuclide Therapy (PRRT): PRRT is a targeted therapy that uses radioactive substances to treat metastatic neuroendocrine tumours by binding to specific receptors on the tumour cells.
  • Liver directed therapy: such as Transarterial Chemoembolisation (TACE) & Selective Internal Radiation Therapy (SIRT)

Radiation therapy

Like other medical therapies, radiation therapy may  offer highly targeted treatment for metastatic neuroendocrine cancer.

  • External beam radiation: High-energy X-rays or other particles are used to target and destroy cancer cells. Radiation therapy can be used to alleviate symptoms or treat localised disease.
  • Radiosurgery: Highly focused radiation beams are used to treat small brain or lung tumours without the need for surgical incisions.

Supportive care

Pain relief measures, including medications and other kinds of pain management, can significantly improve the quality of life for patients with metastatic neuroendocrine cancer.

Symptom management

Addressing specific symptoms such as diarrhoea, flushing, or hormonal imbalances can enhance comfort and well-being.

Nutritional support

Dietary modifications and nutritional supplements may be recommended to manage digestive symptoms and maintain adequate nutrition.

Clinical trials

Additionally, participation in clinical trials may offer access to novel therapies and contribute to advancing our understanding of metastatic neuroendocrine cancer and its treatment options.

To get the best possible results from treatment, it’s crucial for patients with metastatic neuroendocrine cancer to work closely with their healthcare team. This will help all parties determine the most appropriate treatment plan tailored to their specific circumstances. 

Regular follow-up appointments and monitoring are essential to track the progress of the disease and make any necessary adjustments to the treatment plan.

Living with metastatic neuroendocrine cancer

A diagnosis of metastatic neuroendocrine cancer can be overwhelming, but it’s essential to remember that you’re not alone. Support from healthcare professionals, family, and friends is crucial during this journey. Here are some tips for living with metastatic neuroendocrine cancer:

  • Support: seeking support from NECA Telehealth NET Nurse line can help you cope with the emotional and psychological aspects of a neuroendocrine cancer diagnosis.
  • Communication: Maintain open and honest communication with your healthcare team to understand your treatment options and make informed decisions.
  • Lifestyle changes: Implementing healthy lifestyle changes, such as maintaining a balanced diet, staying physically active, and managing stress, can improve your overall well-being.
  • Regular monitoring: Regular check-ups and monitoring of your condition are essential to detect any changes or recurrences early.

Treatment options have expanded in recent years, offering patients a more extended and better quality of life. If you’re struggling with your diagnosis, numerous support options are available for you and your family.

Finding support for metastatic neuroendocrine cancer in Australia

Here are some key resources and organisations that can provide guidance and compassion to those affected by metastatic NETs:

Our organisation – Neuroendocrine Cancer Australia – is dedicated to assisting patients and carers as they manage neuroendocrine cancers, including metastatic NETs. 

We offer a free, confidential telephone support and information line with a specialist NET nurse to answer any questions you might have. Our NET Nurse Hotline is accessible to all NET patients and their families, and you can attend the services in a variety of ways, including:

  • Over the phone on 1300 287 363
  • By filling out our online form
  • In different languages via the Translating and Interpreting Service 

Consider joining or seeking out local support groups for NET patients. These groups often provide a safe space for sharing experiences, concerns, and advice with others who understand what you’re going through.

NECA also has a range of patient support groups established all over Australia. Here, patients can access local knowledge and support from peers who have been diagnosed with an NET before. Participants are more than happy to answer questions about their experiences with NETs and in the healthcare system.

Australia is at the forefront of clinical trial research, and there may be some available for metastatic neuroendocrine cancer treatment. Participating in a clinical trial can offer access to innovative therapies and the opportunity to contribute to advancements in cancer care.

Don’t underestimate the importance of emotional and psychological support from mental health professionals. Psychologists and counsellors can help you and your family cope with the emotional challenges that come with a metastatic neuroendocrine cancer diagnosis.

Remember that you’re not alone. Reach out to these support resources in Australia to access the information, assistance, and compassionate care you need to navigate the challenges of living with this rare condition. Your healthcare team can also provide guidance on available resources and support networks in your community.

Support Australians facing neuroendocrine cancer

Fields marked with an * are required
Donation Frequency *
Help make a difference *

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin